Capricor

is a California-based biotechnology company that develops cell and exosome-based therapeutics for the treatment of novel diseases...
Read more
Capricor President & CEO: Linda Marban

President & CEO

Linda Marban

CEO Approval Rating

90/100

Annual Revenue
$22.3M
Employees
101
Funding
$152.5M

News

Aug 07, 2026
GlobalNewswire
Press Release: Capricor : ROSEN, SKILLED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAPR
Aug 07, 2026
Benzinga
Capricor: INVESTOR NOTICE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit - CAPR
Aug 06, 2026
Vsnewsnetwork
Capricor: Bronstein, Gewirtz & Grossman LLC Urges Capricor Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Aug 06, 2026
GlobalNewswire
Press Release: Capricor : Kaplan Fox Reminds Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors with Significant Losses to Seek a Leadership Role Before Deadline on September 28, 2026
Aug 06, 2026
PR-Inside
Press Release: Capricor : CAPR: Block & Leviton Encourages Capricor Therapeutics Investors to ...
Aug 06, 2026
Nynewsly
Capricor: Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CAPR
Aug 06, 2026
Benzinga
Capricor: CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit
Aug 05, 2026
Benzinga
Capricor: Levi & Korsinsky Reminds Capricor Therapeutics Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 28, 2026 - CAPR
Aug 05, 2026
Financialcontent
Capricor: Lowey Dannenberg, P.C. is Investigating Capricor Therapeutics, Inc. (NASDAQ: CAPR) for Potential Violations of the Federal Securities Laws
Aug 04, 2026
Benzinga
Capricor: CAPR INVESTOR NOTICE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead the Capricor Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces

Capricor Competitors

1Sarepta
2NIPPON SHINYAKU
3Tenaya
4Caladrius
5Cesca
6BioCardia
7Mesoblast
8Asterias Biotherapeutics, Inc.
9Renova Therapeutics
10Sangamo

Trending Companies